ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010

DeVita: No Decision Yet On FCRF Award

July 17, 1987

In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs

January 3, 1986

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

Groups Accepting Need for More Collaboration, NCI Backs Away From Drastic Structural Changes

July 11, 1986